Yahoo · Aug 21, 2026
Mettler-Toledo (MTD) Upgraded to Buy: Here's Why
Mettler-Toledo (MTD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

NYSE · MTD
Healthcare · Medical - Diagnostics & Research
$1,398.58
Down-$8.85 (-0.63%)
Updated Aug 31, 2026, 11:56 AM
SID Score
5.5/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
MTD closed at $1,398.58 after 20 trading sessions, down 3.21% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $1,401.09 | $1,406.925 | $1,391.6171 | $1,398.58 | 202.02K |
| Aug 27, 2026 | $1,406.36 | $1,440.22 | $1,400.61 | $1,407.43 | 146.07K |
| Aug 26, 2026 | $1,392.11 | $1,413.406 | $1,390.81 | $1,398.46 | 97.13K |
| Aug 25, 2026 | $1,413.57 | $1,421.775 | $1,395.985 | $1,402.25 | 116.92K |
| Aug 24, 2026 | $1,393.48 | $1,419.10 | $1,385.675 | $1,398.89 | 164.4K |
| Aug 21, 2026 | $1,385.99 | $1,404.515 | $1,377.0994 | $1,395.25 | 365.59K |
| Aug 20, 2026 | $1,408.57 | $1,447.65 | $1,387.67 | $1,393.23 | 444.6K |
| Aug 19, 2026 | $1,423.17 | $1,456.77 | $1,419.41 | $1,425.09 | 121.75K |
| Aug 18, 2026 | $1,427.61 | $1,427.61 | $1,396.12 | $1,399.67 | 140.59K |
| Aug 17, 2026 | $1,408.96 | $1,428.50 | $1,406.49 | $1,417.42 | 107.55K |
| Aug 14, 2026 | $1,419.44 | $1,423.94 | $1,402.61 | $1,419.02 | 162.02K |
| Aug 13, 2026 | $1,446.23 | $1,446.23 | $1,405.72 | $1,430.76 | 89.59K |
| Aug 12, 2026 | $1,426.11 | $1,442.53 | $1,417.05 | $1,438.53 | 140.65K |
| Aug 11, 2026 | $1,422.19 | $1,445.00 | $1,410.915 | $1,437.18 | 119.75K |
| Aug 10, 2026 | $1,421.35 | $1,442.175 | $1,419.20 | $1,427.53 | 148.55K |
| Aug 7, 2026 | $1,419.49 | $1,435.31 | $1,410.39 | $1,429.46 | 123.7K |
| Aug 6, 2026 | $1,420.90 | $1,423.14 | $1,402.965 | $1,421.24 | 126.97K |
| Aug 5, 2026 | $1,445.11 | $1,474.19 | $1,416.11 | $1,421.52 | 187.72K |
| Aug 4, 2026 | $1,445.00 | $1,457.56 | $1,421.68 | $1,437.00 | 178.1K |
| Aug 3, 2026 | $1,409.61 | $1,455.40 | $1,409.61 | $1,445.00 | 216.29K |
The latest Smart Investors Daily articles mentioning MTD.
MTD research
Company profile and research snapshot.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 4, 2026 | Morgan Stanley | Equal-Weight | — |
| Aug 3, 2026 | Evercore ISI Group | Outperform | — |
| Aug 3, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 3, 2026 | Stifel | Buy | — |
| Aug 3, 2026 | Barclays | Overweight | — |
No generated briefing is available yet.
Yahoo · Aug 21, 2026
Mettler-Toledo (MTD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Yahoo · Aug 10, 2026
This exercise-and-sell transaction captured a gain on options struck at $397.95.
Yahoo · Aug 10, 2026
Head of Process Analytics Gerry Keller liquidated stock worth $342,514 on August 3.
Yahoo · Aug 10, 2026
Salice exercised 415 stock options at $397.95 and immediately sold them at $1,444.62.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning MTD.